SUBSCRIBE
SUBSCRIBE
News   FDA

Almirall Gets FDA Approval for Migraine Drug

June 3, 2009 | 
1 min read
Reuters -- Spanish pharmaceutical firm Almirall on Wednesday said its Almotriptan migraine drug had gained U.S. Food and Drug Administration approval for adolescents.
FDA Approvals Asia Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Pictured: Roche tower in Basel, Switzerland
Manufacturing
Roche Seeks Antibiotic Partner as Rising Manufacturing Costs Drive Supply Rethink
February 24, 2026
 · 
1 min read
 · 
Nick Paul Taylor
screenshot of Marty Makary speaking on the Megyn Kelly Show
Vaccines
FDA’s Makary Backs mRNA Vaccines but Says Companies ‘Can Fund Their Own Research’
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Business people shaking hand in China.
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor